Stay updated on Mepolizumab Efficacy in Severe Asthma Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab Efficacy in Severe Asthma Clinical Trial page.

Latest updates to the Mepolizumab Efficacy in Severe Asthma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedPage footer revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows a new revision number (Revision: v3.4.1) replacing the previous v3.4.0. No study details, eligibility criteria, outcomes, or other critical content appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedThese updates are primarily UI and metadata changes (glossary display option, QC-status labeling, and versioning). They do not alter core study content or eligibility.SummaryDifference0.2%

- Check61 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; no trial content or functionality was changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a new Locations section listing São Paulo as a recruitment site; the prior São Paulo Locations label was removed and the revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Mepolizumab Efficacy in Severe Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab Efficacy in Severe Asthma Clinical Trial page.